Karine Lélu

564 total citations
8 papers, 468 citations indexed

About

Karine Lélu is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Karine Lélu has authored 8 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Genetics and 2 papers in Oncology. Recurrent topics in Karine Lélu's work include Estrogen and related hormone effects (3 papers), Hepatitis B Virus Studies (2 papers) and Hepatitis C virus research (2 papers). Karine Lélu is often cited by papers focused on Estrogen and related hormone effects (3 papers), Hepatitis B Virus Studies (2 papers) and Hepatitis C virus research (2 papers). Karine Lélu collaborates with scholars based in France, Switzerland and Morocco. Karine Lélu's co-authors include Jean‐Charles Guéry, Laurent Delpy, Sophie Laffont, Lucette Pelletier, Britta Engelhardt, Bernard Pipy, Françis Bayard, Jean‐François Arnal, Victorine Douin‐Echinard and Andrée Krust and has published in prestigious journals such as The Journal of Immunology, Journal of Hepatology and European Journal of Immunology.

In The Last Decade

Karine Lélu

8 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karine Lélu France 7 256 110 79 60 57 8 468
Sybille D. Reichardt Germany 11 219 0.9× 51 0.5× 60 0.8× 44 0.7× 45 0.8× 20 467
Mahdi Zamani Iran 14 241 0.9× 191 1.7× 38 0.5× 63 1.1× 30 0.5× 44 603
Nurten Kara Türkiye 15 76 0.3× 117 1.1× 75 0.9× 65 1.1× 66 1.2× 48 580
Rebecca G. Carey United States 7 192 0.8× 157 1.4× 68 0.9× 22 0.4× 39 0.7× 8 464
Mahdi Behzad Iran 14 143 0.6× 58 0.5× 41 0.5× 78 1.3× 45 0.8× 31 448
RP Phipps United States 10 204 0.8× 45 0.4× 66 0.8× 55 0.9× 88 1.5× 14 585
Ömer Ateş Türkiye 15 110 0.4× 51 0.5× 31 0.4× 87 1.4× 51 0.9× 68 620
Roja Motaghedi United States 11 340 1.3× 198 1.8× 31 0.4× 23 0.4× 49 0.9× 16 693
Annabelle Grolleau‐Julius United States 8 331 1.3× 43 0.4× 80 1.0× 17 0.3× 53 0.9× 8 551
Tadafumi Yokoyama Japan 12 232 0.9× 33 0.3× 45 0.6× 45 0.8× 39 0.7× 50 655

Countries citing papers authored by Karine Lélu

Since Specialization
Citations

This map shows the geographic impact of Karine Lélu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Lélu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Lélu more than expected).

Fields of papers citing papers by Karine Lélu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Lélu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Lélu. The network helps show where Karine Lélu may publish in the future.

Co-authorship network of co-authors of Karine Lélu

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Lélu. A scholar is included among the top collaborators of Karine Lélu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Lélu. Karine Lélu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lélu, Karine, Yasmin Schlesinger, Nathalie Silvestre, et al.. (2022). Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models. The Journal of Immunology. 209(1). 99–117. 7 indexed citations
2.
Kratzer, Roland, Karine Lélu, D Schmitt, et al.. (2018). A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model. Human Vaccines & Immunotherapeutics. 14(6). 1417–1422. 6 indexed citations
3.
Garnier, Laure, Sophie Laffont, Karine Lélu, et al.. (2018). Estrogen Signaling in Bystander Foxp3neg CD4+ T Cells Suppresses Cognate Th17 Differentiation in Trans and Protects from Central Nervous System Autoimmunity. The Journal of Immunology. 201(11). 3218–3228. 22 indexed citations
4.
5.
Lélu, Karine, Roland Kratzer, Sarah Dion, et al.. (2015). O031 : TG1050, a novel immunotherapeutic to treat chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models. Journal of Hepatology. 62. S205–S205. 1 indexed citations
6.
Lélu, Karine, Sophie Laffont, Laurent Delpy, et al.. (2011). Estrogen Receptor α Signaling in T Lymphocytes Is Required for Estradiol-Mediated Inhibition of Th1 and Th17 Cell Differentiation and Protection against Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 187(5). 2386–2393. 163 indexed citations
7.
Lélu, Karine, Laurent Delpy, Virginie Robert, et al.. (2010). Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T‐cell homing into the CNS. European Journal of Immunology. 40(12). 3489–3498. 38 indexed citations
8.
Calippe, Bertrand, Victorine Douin‐Echinard, Laurent Delpy, et al.. (2010). 17β-Estradiol Promotes TLR4-Triggered Proinflammatory Mediator Production through Direct Estrogen Receptor α Signaling in Macrophages In Vivo. The Journal of Immunology. 185(2). 1169–1176. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026